| pubmed-article:11553310 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11553310 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:11553310 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
| pubmed-article:11553310 | lifeskim:mentions | umls-concept:C0221912 | lld:lifeskim |
| pubmed-article:11553310 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:11553310 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:11553310 | pubmed:dateCreated | 2001-9-12 | lld:pubmed |
| pubmed-article:11553310 | pubmed:abstractText | Tumor-infiltrating lymphocytes (TILs) are considered to play an important role in the antitumoral immune response. The presence and percentage of CD8-positive tumor-infiltrating T cells have been shown to correlate with differentiation and prognosis in various neoplasms. The aim of this study was to determine the number of CD8-positive T cells in various primary cutaneous B-cell lymphoproliferative disorders and to evaluate its correlation with the histological type of tumor. | lld:pubmed |
| pubmed-article:11553310 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11553310 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11553310 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11553310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11553310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11553310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11553310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11553310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11553310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11553310 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11553310 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11553310 | pubmed:issn | 0303-6987 | lld:pubmed |
| pubmed-article:11553310 | pubmed:author | pubmed-author:AVISK EKE | lld:pubmed |
| pubmed-article:11553310 | pubmed:author | pubmed-author:MüllerBB | lld:pubmed |
| pubmed-article:11553310 | pubmed:author | pubmed-author:KempsHH | lld:pubmed |
| pubmed-article:11553310 | pubmed:author | pubmed-author:ScherfR RRR | lld:pubmed |
| pubmed-article:11553310 | pubmed:author | pubmed-author:KamarashevJJ | lld:pubmed |
| pubmed-article:11553310 | pubmed:author | pubmed-author:SchaererLL | lld:pubmed |
| pubmed-article:11553310 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11553310 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:11553310 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11553310 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11553310 | pubmed:pagination | 448-52 | lld:pubmed |
| pubmed-article:11553310 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:meshHeading | pubmed-meshheading:11553310... | lld:pubmed |
| pubmed-article:11553310 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11553310 | pubmed:articleTitle | Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders. | lld:pubmed |
| pubmed-article:11553310 | pubmed:affiliation | Department of Dermatology, University of Zürich, Zürich, Switzerland. | lld:pubmed |
| pubmed-article:11553310 | pubmed:publicationType | Journal Article | lld:pubmed |
